Cargando…
Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis
Bromodomain and extra-terminal (BET) protein inhibitors have been shown to effectively inhibit tumorgenesis and ameliorate pulmonary fibrosis by targeting bromodomain proteins that bind acetylated chromatin markers. However, their pharmacological effects in renal fibrosis remain unclear. In this stu...
Autores principales: | Xiong, Chongxiang, Masucci, Monica V., Zhou, Xiaoxu, Liu, Na, Zang, Xiujuan, Tolbert, Evelyn, Zhao, Ting C., Zhuang, Shougang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342478/ https://www.ncbi.nlm.nih.gov/pubmed/27732564 http://dx.doi.org/10.18632/oncotarget.12498 |
Ejemplares similares
-
Pharmacological inhibition of Src kinase protects against acute kidney injury in a murine model of renal ischemia/reperfusion
por: Xiong, Chongxiang, et al.
Publicado: (2017) -
Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis
por: Yan, Yanli, et al.
Publicado: (2016) -
Pharmacologic Targeting of BET Proteins Attenuates Hyperuricemic Nephropathy in Rats
por: Xiong, Chongxiang, et al.
Publicado: (2021) -
Pharmacological and Genetic Inhibition of HDAC4 Alleviates Renal Injury and Fibrosis in Mice
por: Shen, Fengchen, et al.
Publicado: (2022) -
Blocking the Class I Histone Deacetylase Ameliorates Renal Fibrosis and Inhibits Renal Fibroblast Activation via Modulating TGF-Beta and EGFR Signaling
por: Liu, Na, et al.
Publicado: (2013)